US 11,911,172 B2
Automated allergy office system and method
Ty L. Prince, Knoxville, TN (US); and Herman J. Novak, Maryville, TN (US)
Filed by Ty L. Prince, Knoxville, TN (US); and Herman J. Novak, Maryville, TN (US)
Filed on Dec. 9, 2022, as Appl. No. 18/078,856.
Application 18/078,856 is a continuation in part of application No. 17/992,125, filed on Nov. 22, 2022, granted, now 11,696,722.
Application 17/992,125 is a continuation in part of application No. 17/468,132, filed on Sep. 7, 2021, granted, now 11,369,782.
Application 17/992,125 is a continuation in part of application No. 18/078,856.
Application 18/078,856 is a continuation in part of application No. 17/402,413, filed on Aug. 13, 2021, granted, now 11,517,249.
Prior Publication US 2023/0240588 A1, Aug. 3, 2023
Int. Cl. A61B 5/00 (2006.01); G16H 10/60 (2018.01); G16H 20/00 (2018.01)
CPC A61B 5/411 (2013.01) [A61B 5/4836 (2013.01); A61B 5/7445 (2013.01); A61B 2560/06 (2013.01); G16H 10/60 (2018.01); G16H 20/00 (2018.01)] 16 Claims
OG exemplary drawing
 
1. An automated allergy office method in the sequence set forth to configure treatment to address allergy issues of a patient, said patient having a first allergy condition, said automated allergy office method comprising:
a. delivering a small amount of a first allergen to a first test site via a multiple test applicator as said multiple test applicator delivers a small amount of a second allergen to a second test site during allergen deposition, said multiple test applicator being cooperatively engageable with a fluid tray during said allergen loading, said multiple test applicator being cooperatively engageable with skin of said patient during said allergen deposition;
b. capturing a first image of said first test site and a first image of said second test site after said allergen deposition using a first viewing device, said first viewing device being an augmented reality viewing device;
c. capturing a second image of said first test site and a second image of said second test site fifteen minutes after said allergen deposition with said first viewing device or a second viewing device, said second viewing device being an augmented reality viewing device, said first allergy condition being detectable as a first wheal forms at said first test site or second test site; and
d. developing a computer-generated treatment plan using machine learning for said patient having said first allergy condition, said computer-generated treatment plan being a step-by-step procedure for a medical professional, said patient having an electronic medical record, said computer-generated treatment plan being stored in a medical database for treating patients with said first allergy condition.